Paul McBarron
2010
In 2010, Paul McBarron earned a total compensation of $436.1K as Executive Vice President, Finance, Chief Operating Officer, Chief Financial Officer, and Secretary at Cyclacel Pharmaceuticals, a 11% increase compared to previous year.
Compensation breakdown
| Bonus | $36,350 |
|---|---|
| Option Awards | $92,250 |
| Salary | $289,768 |
| Other | $17,732 |
| Total | $436,100 |
McBarron received $289.8K in salary, accounting for 66% of the total pay in 2010.
McBarron also received $36.4K in bonus, $92.3K in option awards and $17.7K in other compensation.
Rankings
In 2010, Paul McBarron's compensation ranked 8,159th out of 10,439 executives tracked by ExecPay. In other words, McBarron earned more than 21.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,159 out of 10,439 | 22nd |
Division Manufacturing | 3,038 out of 3,838 | 21st |
Major group Chemicals And Allied Products | 732 out of 926 | 21st |
Industry group Drugs | 516 out of 685 | 25th |
Industry Pharmaceutical Preparations | 379 out of 481 | 21st |
Source: SEC filing on April 19, 2012.
McBarron's colleagues
We found two more compensation records of executives who worked with Paul McBarron at Cyclacel Pharmaceuticals in 2010.
News
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2023 pay slips 13% to $661K
May 7, 2024
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2022 pay falls 43% to $764K
April 28, 2023
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2021 pay slips 5% to $1.3M
April 26, 2022
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2020 pay jumps 39% to $1.4M
April 29, 2021
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2019 pay jumps 35% to $1M
May 12, 2020